Type 2 diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Voluntarily participating and signing a written informed consent before enrollment; 2. Aged 18-70 years; 3. Having a clinical diagnosis of diabetes for >= 3 months,meet the WHO 1999 diagnostic criteria and willing to abide the operation of the equipment required to wear a continuous glucose monitoring system.
Exclusion criteria
Exclusion criteria: 1. Pregnancy, lactating or recent family planning women; 2. Patients with liver (glutamic pyruvic transaminase or aspartate aminotransferase level of more than 3 times the upper limit of normal range) and kidney dysfunction (creatinine more than 1.5 times the upper limit of normal range); 3. Patients with tape allergy history or sensitive constitution; 4. Patients with uncontrollable hypertension (180/120 mmHg); 5. Patients with severe cardiovascular and cerebrovascular diseases; 6. Patients with skin abnormalities hindering the wearing of probe, such as psoriasis, rash and infection; 7. Patients with anemia (Hb <= 100 g/L), severe infection, malignant tumor and active bleeding; 8. Patients with coagulation function (prothrombin time) exceeding the upper limit of normal range; 9. BMI < 18.5 kg/m^2; 10. Patients with severe dehydration and edema; 11. Patients with psychosis or a medical history; 12. Patients who are judged by the researcher to be unsuitable to participate in this project.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| accuracy;Consistency; | — |
Countries
China
Contacts
Nanjing First Hospital